2017
DOI: 10.1016/j.immuni.2017.09.010
|View full text |Cite
|
Sign up to set email alerts
|

By Capturing Inflammatory Lipids Released from Dying Cells, the Receptor CD14 Induces Inflammasome-Dependent Phagocyte Hyperactivation

Abstract: SUMMARY A heterogeneous mixture of lipids called oxPAPC, derived from dying cells, can hyperactivate dendritic cells (DCs) but not macrophages. Hyperactive DCs are defined by their ability to release interleukin-1 (IL-1) while maintaining cell viability, endowing these cells with potent aptitude to stimulate adaptive immunity. Herein, we found that the bacterial lipopolysaccharide receptor CD14 captured extracellular oxPAPC and delivered these lipids into the cell to promote inflammasome-dependent DC hyperacti… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

20
183
1
3

Year Published

2018
2018
2023
2023

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 165 publications
(218 citation statements)
references
References 36 publications
(71 reference statements)
20
183
1
3
Order By: Relevance
“…In our study, IL-27 amplified sCD14 production in THP-1 cells but not in PMA-THP-1 cells, primary monocytes, or primary macrophages. Surprisingly, IL-27 added prior to recombinant CD14 induced TNF-␣ production in the absence of LPS, which may suggest that IL-27 amplified an alternate CD14 signaling mechanism, similar to one discovered recently (91). Specifically, tissue injury releases danger-associated molecular patterns (DAMPs), which induce CD14 internalization to inhibit LPS-TLR4 responses (91).…”
Section: Figure 8 the Addition Of Recombinant Cd14 With Il-27 Enhancmentioning
confidence: 78%
“…In our study, IL-27 amplified sCD14 production in THP-1 cells but not in PMA-THP-1 cells, primary monocytes, or primary macrophages. Surprisingly, IL-27 added prior to recombinant CD14 induced TNF-␣ production in the absence of LPS, which may suggest that IL-27 amplified an alternate CD14 signaling mechanism, similar to one discovered recently (91). Specifically, tissue injury releases danger-associated molecular patterns (DAMPs), which induce CD14 internalization to inhibit LPS-TLR4 responses (91).…”
Section: Figure 8 the Addition Of Recombinant Cd14 With Il-27 Enhancmentioning
confidence: 78%
“…CD14 acts as a co-receptor for the pattern recognition receptors TLR1-4, 6, 7 and 9 [41]. It delivers the pathogen-associated molecule lipopolysaccharide (LPS), which is produced exclusively by gram-negative bacteria, to TLR4 resulting in pro-inflammatory responses [42]. The transmembrane glycoprotein TREM1, which is found in monocytes, macrophages and neutrophils, is also heavily involved in TLR4 signaling, i.e., it promotes inflammation in response to bacterial infection [43].…”
Section: Discussionmentioning
confidence: 99%
“…microenvironment, including chemotactic and activatory effects on dendritic cells 17 and its ability to induce cell death through pyroptosis (which is associated with inflammasome activation and IL-1β production; see also below) 159 . Both urate and oxidized phospholipids can trigger inflammasome activation in living myeloid cells 160 , whereas nucleic acids can be recognized by a plethora of pattern recognition receptors, including Toll-like receptor 3 (TLR3), TLR9, cGAS, absent in melanoma 2 (AIM2) and multiple Rigi-like receptors (RLRs), resulting in myeloid cell activation 159 . HGMB1 also mediates immunostimulatory effects upon binding to advanced glycosylation end product-specific receptor (AGER) and TLR4, as does F-actin upon binding to C-type lectin domain family 4 (CLEC4) 17 .…”
Section: Damage-associated Molecular Patternsmentioning
confidence: 99%